HighQC™ Human IPSC-Derived Hepatocytes (ABC-SC2119)

These hepatocytes overcome the functionality, reproducibility, and availability limitations of existing primary cell and tumor-derived cell models by providing the following:

Relevant hepatic functionality and phenotypic stability
Expression of clinical targets that are relevant for liver and metabolic disease
Compatibility with a wide range of 3D and microphysiological systems
Quality-controlled manufacturing and batch reproducibility
Ready supply in a cryopreserved format